Edgar Wachenheim Greenhaven Associates
Edgar Wachenheim III is the long-time leader of Greenhaven Associates, a concentrated value-oriented investment firm. Greenhaven is known for large positions in a limited number of equities and a multi-year investment horizon. Wachenheim’s approach emphasizes intrinsic value, patience, and a willingness to look different from the index.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Short S&P500
SH
|
+$1.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$465M |
| 2 |
Deere & Co
DE
|
+$223M |
| 3 |
CF Industries
CF
|
+$123M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$78.6M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$75.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 50.47% |
| 2 | Financials | 30.6% |
| 3 | Consumer Staples | 0.09% |
| 4 | Materials | 0.07% |
| 5 | Healthcare | 0.05% |
Similar funds
Edgar Wachenheim's Q2 2021 Portfolio in Review
As of Q2 2021, Edgar Wachenheim held 24 positions worth $3.42B, down 23% from $4.43B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Edgar Wachenheim withdrew a net $1.23B in Q2 2021, closing 4 positions and reducing 14 holdings. Its most notable exit was Deere & Co, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 43% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Edgar Wachenheim added an estimated $1.19M to ProShares Short S&P500.
- Edgar Wachenheim added most to ProShares Short S&P500 in Q2 2021, an estimated $1.19M increase.
- Edgar Wachenheim's biggest Q2 2021 reduction was Morgan Stanley, cutting an estimated $465M.
- Edgar Wachenheim fully exited Deere & Co in Q2 2021, selling an estimated $223M.
- Edgar Wachenheim's ten largest holdings make up 99% of its $3.42B portfolio in Q2 2021.
- Edgar Wachenheim opened 0 new positions and closed 4 in Q2 2021.
- Edgar Wachenheim's portfolio value fell 23% quarter-over-quarter to $3.42B.
Based on Greenhaven Associates's 13F filing for Q2 2021, filed 2 Aug 2021.